“Kisolite” is a mineral formed in nature over thousands of years.
There are several theories to explain the unique geological occurrence that resulted in the mineral clay deposit. The most likely explanation is a volcanic eruption causing a pyroclastic flow as an event under continental glacial ice, around 14,500 years ago. This flow, or Lahar, of ancient glacial ice melt and fine mineral laden ash, then filled a natural granite basin, known today as the Kisameet Bay Clay Deposit.
First Nation's oral history confirms its use as a healing clay. The actual date of discovery is unknown but it is commonly accepted as pre-European.
In the 1930’s – 50’s the mineral was studied at MIT by Dr. Ernst A. Hauser. He determined the mineral clay had many colloidal properties. The vast amount of research findings compiled by Hauser and other notable scientists throughout this period is summed up in his final paper entitled the “Kisameet Bay Clay Deposit”. Three key statements to note in that paper are the foundation of Kisolite Corp’s purpose today:
- “this aluminum silicate differs pronouncedly from any known clay mineral.”
- “certain fractions demonstrate pronounced antibiotic activity”
- “deserves more attention from a medical point of view”
Based upon this important work from MIT, the company sponsored a multi-disciplinary research endeavor led at The University of British Columbia. In January 2016 a paper entitled “Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens” was published in mBio, the Journal of the American Society of Microbiology. The research confirmed that some forms and fractions of the mineral clay demonstrated antimicrobial properties against MDR (multi-drug resistant) strains of bacteria or “Super Bugs”.
Kisolite Corp has undertaken the important and urgent task of furthering this discovery. This includes increasing our understanding of the unique mineral composition itself. Kisolite is not an antibiotic per se, but the mineral content, particle size, particle shape and surface area each play a role in the multifactorial mode of action. Kisolite’s historical efficacy and its use as a topical and dietary health product are all important components of understanding Kisolite’s potential. This may lead to positive disruptive impacts in present-day health practices, and new products with broad applications for human and animal health.
Kisolite Corp is already on-target for commercialization for a variety of consumer markets for applications such as Nutraceuticals, dietary and food supplements, and livestock feed additives. At the present time, sales of unformulated Kisolite® clay powder have begun under the Cosmetic Ingredient brand “Kisameet” (INCI Tradename is Kisameet Clay, under INCI Category: Clay) using a growing number of select Cosmetic Ingredient Distributors.